Drug Approval | October 19, 2021
Dr Reddy’s Labs announces U.S. FDA approval for Lenalidomide capsules
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
The company is eligible for 180 days of generic drug exclusivity for Lenalidomide capsules, 2.5 mg and 20 mg
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
The company plans to raise US $ 15 million
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
The Pune centre expands its presence beyond Bangalore and Hyderabad
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
This opens up a huge market for the company’s Magnezis implants in India
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
Subscribe To Our Newsletter & Stay Updated
